IRADIMED CORPORATION to Hold 2020 Second Quarter Financial Results Conference Call on July 30th
16 juil. 2020 07h00 HE
|
iRadimed Corporation
WINTER SPRINGS, Fla., July 16, 2020 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2020 second quarter financial results before the market...
IRADIMED CORPORATION Names Roger Susi as President and Chief Executive Officer
29 mai 2020 07h00 HE
|
iRadimed Corporation
WINTER SPRINGS, Fla., May 29, 2020 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), announced today that its Board of Directors has appointed Roger Susi to resume his duties as the Company’s...
IRADIMED CORPORATION Announces Issuance of U.S. Patent
11 mai 2020 07h00 HE
|
iRadimed Corporation
WINTER SPRINGS, Fla., May 11, 2020 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD), today announced the issuance by the U.S. Patent and Trademark Office of a patent that expands on previous...
IRADIMED CORPORATION Announces First Quarter 2020 Financial Results
30 avr. 2020 07h00 HE
|
iRadimed Corporation
Reports first quarter 2020 revenue of $8.7 million, GAAP diluted EPS of $0.14 and non-GAAP diluted EPS of $0.18Reports combined cash and investments of $47.4 million as of March 31, 2020 WINTER...
IRADIMED CORPORATION to Hold 2020 First Quarter Financial Results Conference Call on April 30th
16 avr. 2020 07h00 HE
|
iRadimed Corporation
WINTER SPRINGS, Fla., April 16, 2020 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2020 first quarter financial results before the...
IRADIMED CORPORATION Withdraws 2020 Financial Guidance Due to Uncertainties from the Effects of COVID-19
07 avr. 2020 07h00 HE
|
iRadimed Corporation
WINTER SPRINGS, Fla., April 07, 2020 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced that it expects to report first quarter 2020 revenue of $8.6 million to $8.7 million and is...
IRADIMED CORPORATION Announces the Appointment of Lynn Neuhardt as Vice President of Research and Development
12 mars 2020 07h00 HE
|
iRadimed Corporation
WINTER SPRINGS, Fla., March 12, 2020 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced the appointment of Lynn Neuhardt as Vice President of Research and Development, effective March...
IRADIMED CORPORATION to Present at the 32nd Annual Roth Conference
06 mars 2020 09h50 HE
|
iRadimed Corporation
WINTER SPRINGS, Fla., March 06, 2020 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) today announced that Leslie McDonnell, President and Chief Executive Officer, will present at the 32nd...
IRADIMED CORPORATION Announces Retirement of Francis Casey and the Appointment of Steven Kachelmeyer as Vice President of Regulatory Affairs and Quality Assurance
26 févr. 2020 07h00 HE
|
iRadimed Corporation
WINTER SPRINGS, Fla., Feb. 26, 2020 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced the retirement of Francis Casey, Vice President of Regulatory Affairs and Quality Assurance,...
IRADIMED CORPORATION Announces Fourth Quarter 2019 Financial Results
06 févr. 2020 07h00 HE
|
iRadimed Corporation
Reports fourth quarter 2019 revenue of $10.9 million, GAAP diluted EPS of $0.26 and non-GAAP diluted EPS of $0.30Renewed CE Mark for patient vital signs monitor and shipped associated backlog during...